-The Indian Express     Mumbai: It's been eight months since the state government launched ‘Manodhairya Yojana', a scheme to provide monetary relief and rehabilitation for rape and acid attack victims, including women and children. But with little advocacy, lack of counsellors in civic-run hospitals, poor post-trauma support as mandated by the scheme, and most importantly, policy apathy, ‘Manodhairya' risks being a laudable scheme just on paper. AAMIR KHAN and TABASSUM BARNAGARWALA speak...

-The Business Standard   Or, why our subsidy and tax policies have been almost exactly wrong Thomas Piketty's seminal book on inequality, Capital in the Twenty-First Century, comes at a fortuitous time. Although inequality has been a well-discussed issue in India for some time now, the success of the book contributes by sharpening the debate. It complements the McKinsey Global Institute's (MGI) report titled "From poverty to empowerment: India's imperative for jobs, growth,...

-The Indian Express   MGNREGA is beset with failures of planning, execution, monitoring and accountability. This election season, we have seen the BJP seeking the people's mandate on the slogan "sab ka saath, sab ka vikas". The Congress harps primarily on a "we gave you" list. The first in this list is the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGA). The 11th Five Year Plan recognised that 30 crore people lived below the...

-Live Mint   Strong political commitment is needed to build a system of universal health coverage and better regulations   Life expectancy in India has more than doubled since independence, to 65 years, from just 32 in 1950. The infant mortality rate has been cut by two-thirds since 1971. Smallpox and guinea worm have been eradicated, the spread of HIV/AIDS has been contained, and the World Health Organization has declared India polio-free.   Yet for all...

-The Hindu   No one can attack India's well-founded Intellectual Property regime as being weak merely because a drug that is claimed to be an invention fails the test of law India and its intellectual property (IP) laws have been the subject of sharp criticism recently. Now, there is talk of the government invoking emergency provisions with regard to Dasatinib, a cancer drug. The decibel level may go up several notches. Let us look...